Which mechanism of action is responsible for the bronchodilatory effect of theophylline?

Explanation

## Theophylline: Mechanism of Bronchodilation **Key Point:** Theophylline is a non-selective phosphodiesterase (PDE) inhibitor AND a non-selective adenosine receptor antagonist. Both mechanisms contribute to its bronchodilatory effect. **High-Yield:** Theophylline's dual mechanism distinguishes it from beta-2 agonists (which work via cAMP) and anticholinergics (which block muscarinic receptors). This makes theophylline a unique bronchodilator with a narrow therapeutic window (10–20 μg/mL). ### Mechanism Breakdown 1. **Adenosine Receptor Antagonism:** - Blocks adenosine A~1~ and A~2~ receptors on airway smooth muscle - Adenosine normally promotes bronchoconstriction; blocking it relieves constriction 2. **Phosphodiesterase Inhibition:** - Inhibits PDE (especially PDE-3 and PDE-4) non-selectively - Increases intracellular cAMP in smooth muscle cells - Elevated cAMP → smooth muscle relaxation and bronchodilation **Clinical Pearl:** Theophylline also has additional effects: anti-inflammatory action, improved diaphragmatic contractility, and mild stimulation of respiratory drive — making it useful in COPD and asthma, though it has largely been replaced by more selective agents. **Mnemonic:** **TAPED** — Theophylline's Actions: **P**hosphodiesterase inhibition + **A**denosine antagonism + **D**iaphragmatic stimulation + **E**xtra effects (anti-inflammatory). ### Comparison with Other Bronchodilators | Agent | Primary Mechanism | Secondary Mechanism | cAMP Effect | | --- | --- | --- | --- | | Beta-2 agonist | β~2~ receptor agonism | — | ↑↑↑ (direct) | | Theophylline | PDE inhibition + adenosine antagonism | Adenosine blockade | ↑ (indirect) | | Anticholinergic | Muscarinic M~3~ antagonism | — | — | | Leukotriene antagonist | CysLT~1~ receptor antagonism | — | — |